Celcuity (CELC) Net Cash Flow (2016 - 2025)
Celcuity (CELC) reported Net Cash Flow of $91.5 million for Q4 2025, up 822.63% on a YoY basis from $9.9 million in Q4 2024, and up 227.8% quarter-over-quarter from $27.9 million in Q3 2025.
Celcuity (CELC) Net Cash Flow (2016 - 2025) Analysis & Trends
Celcuity has reported Net Cash Flow for 10 years, with the latest figure at $91.5 million in Q4 2025.
- For the quarter ending Q4 2025, Net Cash Flow rose 822.63% year-over-year to $91.5 million; the trailing twelve-month figure through Dec 2025 stood at $143.2 million (up 1857.34% YoY), and the FY2025 full-year result was $143.2 million, up 1857.34% from the prior year.
- Net Cash Flow for Q4 2025 stood at $91.5 million, up from $27.9 million in the prior quarter.
- The five-year high for Net Cash Flow was $91.5 million in Q4 2025, with the low at -$32.9 million in Q4 2022.
- Historically, Net Cash Flow has averaged $7.7 million across 5 years, with a median of -$102000.0 in 2024.
- The largest YoY upside for Net Cash Flow was 4051.85% in 2025 against a maximum downside of 1193.66% in 2025.
- Celcuity's Net Cash Flow stood at -$6.1 million in 2021, then slumped by 441.28% to -$32.9 million in 2022, then jumped by 114.9% to $4.9 million in 2023, then soared by 102.17% to $9.9 million in 2024, then surged by 822.63% to $91.5 million in 2025.
- The last three Net Cash Flow figures came in at $91.5 million (Q4 2025), $27.9 million (Q3 2025), and $29.9 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 625.70 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -2.44 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 457.40 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 664,983.53 |
| 10 | Celcuity | 4.14 Bn | 3.42 Bn | - | 91.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 91.45 Mn |
| Dec 31, 2025 | 91.45 Mn |
| Sep 30, 2025 | 27.90 Mn |
| Sep 30, 2025 | 27.90 Mn |
| Jun 30, 2025 | 29.88 Mn |
| Jun 30, 2025 | 29.88 Mn |
| Mar 31, 2025 | -6.04 Mn |
| Mar 31, 2025 | -6.04 Mn |
| Dec 31, 2024 | 9.91 Mn |
| Dec 31, 2024 | 9.91 Mn |
| Sep 30, 2024 | -17.86 Mn |
| Sep 30, 2024 | -17.86 Mn |
| Jun 30, 2024 | -756,000.00 |
| Jun 30, 2024 | -756,000.00 |
| Mar 31, 2024 | 552,000.00 |
| Mar 31, 2024 | 552,000.00 |
| Dec 31, 2023 | 4.90 Mn |
| Dec 31, 2023 | 4.90 Mn |
| Sep 30, 2023 | -6.48 Mn |
| Sep 30, 2023 | -6.48 Mn |